Aspirin (delayed release tablet)

Jump to navigation Jump to search
Aspirin (delayed release tablet)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Aspirin (delayed release tablet) is an analgesic that is FDA approved for the treatment of minor aches and pains. Common adverse reactions include dyspepsia, hypoprothrombinemia, thrombocytopenia, hypersensitivity, cholestatic hepatitis, and tinnitus.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications
  • Temporarily relieves minor aches and pains.
  • For other uses, see your doctor, but do not use for more than 10 days without consulting your doctor because serious side effects may occur.
Dosage
  • Drink a full glass of water with each dose.
  • Adults and children 12 years and over: take 4 to 8 tablets every 4 hours not to exceed 48 tablets in 24 hours unless directed by a doctor.
  • Children under 12 years: consult a doctor.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (delayed release tablet) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (delayed release tablet) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Aspirin (delayed release tablet) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (delayed release tablet) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (delayed release tablet) in pediatric patients.

Contraindications

There is limited information regarding Aspirin (delayed release tablet) Contraindications in the drug label.

Warnings

  • Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
  • Allergy alert: Aspirin may cause a severe allergic reaction, which may include:
  • Hives
  • Facial swelling
  • Shock
  • Asthma (wheezing)
  • Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
  • Are age 60 or older
  • Have had stomach ulcers or bleeding problems
  • Take a blood thinning (anticoagulant) drug
  • Take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
  • Have 3 or more alcoholic drinks every day while using this product
  • Take more or for a longer time than directed.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Aspirin (delayed release tablet) in the drug label.

Postmarketing Experience

Dyspepsia, hypoprothrombinemia, thrombocytopenia, hypersensitivity, cholestatic hepatitis, tinnitus.

Drug Interactions

There is limited information regarding Aspirin (delayed release tablet) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Aspirin (delayed release tablet) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Aspirin (delayed release tablet) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Aspirin (delayed release tablet) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Aspirin (delayed release tablet) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Aspirin (delayed release tablet) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Aspirin (delayed release tablet) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Aspirin (delayed release tablet) in patients who are immunocompromised.

Administration and Monitoring

Administration

Monitoring

There is limited information regarding Monitoring of Aspirin (delayed release tablet) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Aspirin (delayed release tablet) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Aspirin (delayed release tablet) in the drug label.

Pharmacology

Template:Px
Template:Px
Aspirin (delayed release tablet)
Systematic (IUPAC) name
2-(acetoxy)benzoic acid
Identifiers
CAS number 50-78-2
ATC code A01AD05 B01AC06 (WHO), N02BA01 (WHO)
PubChem 2244
DrugBank DB00945
Chemical data
Formula Template:OrganicBox atomTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox 
Mol. mass 180.157 g/mol
SMILES eMolecules & PubChem
Synonyms 2-acetoxybenzoic acid
acetylsalicylate
acetylsalicylic acid
O-acetylsalicylic acid
Physical data
Density 1.40 g/cm³
Melt. point 136 °C (277 °F)
Boiling point 140 °C (284 °F) (decomposes)
Solubility in water 3 mg/mL (20 °C)
Pharmacokinetic data
Bioavailability 80–100%[1]
Protein binding 80–90%[2]
Metabolism Hepatic, (CYP2C19 and possibly CYP3A), some is also hydrolysed to salicylate in the gut wall.[2]
Half life Dose-dependent; 2–3 hours for low doses, 15–30 hours for large doses.[2]
Excretion Urine (80–100%), sweat, saliva, feces[1]
Therapeutic considerations
Pregnancy cat.

C(AU) C(US)

Legal status

Pharmacy Only (S2)(AU) GSL(UK) OTC(US)

Routes Most commonly oral, also rectal, lysine acetylsalicylate may be given intravenously or intramuscularly

Mechanism of Action

There is limited information regarding Aspirin (delayed release tablet) Mechanism of Action in the drug label.

Structure

There is limited information regarding Aspirin (delayed release tablet) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Aspirin (delayed release tablet) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Aspirin (delayed release tablet) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Aspirin (delayed release tablet) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Aspirin (delayed release tablet) in the drug label.

How Supplied

There is limited information regarding Aspirin (delayed release tablet) How Supplied in the drug label.

Storage

There is limited information regarding Aspirin (delayed release tablet) Storage in the drug label.

Images

Drug Images

Aggrenox NDC 05970001.jpg

Drug Name: Aggrenox
Ingredient(s): aspirin[aspirin], dipyridamole[dipyridamole]
Imprint: 01A;
Dosage: 25 mg
Color(s):
Shape: Capsule
Size (mm): 24
Score: 1
NDC:05970001

Drug Label Author: Boehringer Ingelheim Pharmaceuticals, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Ascomp with Codeine NDC 519910074.jpg

Drug Name: Ascomp with Codeine
Ingredient(s): Butalbital[Butalbital], Aspirin[Aspirin], Caffeine[Caffeine], Codeine Phosphate[Codeine]
Imprint: B074
Dosage: 325 mg
Color(s):
Shape: Capsule
Size (mm): 22
Score: 1
NDC:519910074

Drug Label Author: Breckenridge Pharmaceutical, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Aspir Low NDC 09047704.jpg

Drug Name: Aspir Low
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: N
Dosage: 81 mg
Color(s): Yellow
Shape: Round
Size (mm): 7
Score: 1
NDC:09047704

Drug Label Author: Major Pharmaceuticals

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin EC NDC 01821061.jpg

Drug Name: Aspirin EC
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: N
Dosage: 81 mg
Color(s): Yellow
Shape: Round
Size (mm): 7
Score: 1
NDC:01821061

Drug Label Author: Goldline Laboratories, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin NDC 05363086.jpg

Drug Name: Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: AP;121
Dosage: 81 mg
Color(s): Yellow
Shape: Round
Size (mm): 8
Score: 1
NDC:05363086

Drug Label Author: Rugby Laboratories Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin NDC 06030024.jpg

Drug Name: Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: AZ013
Dosage: 81 mg
Color(s): Orange
Shape: Round
Size (mm): 8
Score: 1
NDC:06030024

Drug Label Author: Qualitest Pharmaceutical, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin NDC 09044040.jpg

Drug Name: Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: L467
Dosage: 81 mg
Color(s): Orange
Shape: Round
Size (mm): 8
Score: 1
NDC:09044040

Drug Label Author: Major Pharmaceuticals

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin NDC 09046288.jpg

Drug Name: Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: TCL;334;UPPER;LOWER;PLAIN
Dosage: 81 mg
Color(s): Orange
Shape: Round
Size (mm): 8
Score: 1
NDC:09046288

Drug Label Author: Major Pharmaceuticals

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin NDC 508440157.jpg

Drug Name: Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: ASPIRIN;44157
Dosage: 325 mg
Color(s): White
Shape: Round
Size (mm): 11
Score: 1
NDC:508440157

Drug Label Author: L.N.K. International, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin NDC 508440249.jpg

Drug Name: Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: ASPIRIN;44249
Dosage: 325 mg
Color(s): White
Shape: Round
Size (mm): 11
Score: 1
NDC:508440249

Drug Label Author: L.N.K. International, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Butalbital Aspirin Caffeine and Codeine Phosphate NDC 05913546.jpg

Drug Name: Butalbital, Aspirin, Caffeine and Codeine Phosphate
Ingredient(s): CODEINE PHOSPHATE[CODEINE ANHYDROUS], BUTALBITAL[BUTALBITAL], CAFFEINE[CAFFEINE], ASPIRIN[ASPIRIN]
Imprint: WATSON;3546
Dosage: 325 mg
Color(s):
Shape: Capsule
Size (mm): 22
Score: 1
NDC:05913546

Drug Label Author: Watson Laboratories, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
Butalbital Aspirin and Caffeine NDC 01431785.jpg

Drug Name: Butalbital, Aspirin and Caffeine
Ingredient(s): BUTALBITAL[BUTALBITAL], ASPIRIN[ASPIRIN], CAFFEINE[CAFFEINE]
Imprint: Westward;785
Dosage: 325 mg
Color(s): White
Shape: Round
Size (mm): 11
Score: 1
NDC:01431785

Drug Label Author: West-ward Pharmaceutical Corp

This pill image is provided by the National Library of Medicine's PillBox.
Butalbital Aspirin and Caffeine NDC 05913219.jpg

Drug Name: Butalbital, Aspirin, and Caffeine
Ingredient(s): BUTALBITAL[BUTALBITAL], ASPIRIN[ASPIRIN], CAFFEINE[CAFFEINE]
Imprint: WATSON;3219
Dosage: 325 mg
Color(s):
Shape: Capsule
Size (mm): 22
Score: 1
NDC:05913219

Drug Label Author: Watson Laboratories, Inc.

This pill image is provided by the National Library of Medicine's PillBox.
File:Butalbital Aspirin and Caffeine Tablets NDC 06032548.jpg

Drug Name: Butalbital, Aspirin and Caffeine Tablets
Ingredient(s): ASPIRIN[ASPIRIN], BUTALBITAL[BUTALBITAL], CAFFEINE[CAFFEINE]
Imprint: West;ward;785
Dosage: 325 mg
Color(s): White
Shape: Round
Size (mm): 7
Score: 1
NDC:06032548

Drug Label Author: Qualitest

This pill image is provided by the National Library of Medicine's PillBox.
Enteric Coated Aspirin NDC 05363313.jpg

Drug Name: Enteric Coated Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: T
Dosage: 325 mg
Color(s): Orange
Shape: Round
Size (mm): 11
Score: 1
NDC:05363313

Drug Label Author: Rugby Laboratories, Inc

This pill image is provided by the National Library of Medicine's PillBox.
Enteric Coated Aspirin NDC 06030169.jpg

Drug Name: Enteric Coated Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: T;A
Dosage: 325 mg
Color(s): Orange
Shape: Round
Size (mm): 11
Score: 1
NDC:06030169

Drug Label Author: Qualitest Pharmaceuticals

This pill image is provided by the National Library of Medicine's PillBox.
Low Strength Chewable Aspirin NDC 578960911.jpg

Drug Name: Low Strength Chewable Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: AZ;013
Dosage: 81 mg
Color(s): Orange
Shape: Round
Size (mm): 7
Score: 1
NDC:578960911

Drug Label Author: Geri-Care Pharmaceutical Corp

This pill image is provided by the National Library of Medicine's PillBox.
Micro-Coated Aspirin NDC 05363305.jpg

Drug Name: Micro-Coated Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: TCL;011
Dosage: 325 mg
Color(s): White
Shape: Round
Size (mm): 10
Score: 1
NDC:05363305

Drug Label Author: Rugby Laboratories, Inc

This pill image is provided by the National Library of Medicine's PillBox.
Regular Strength Aspirin EC NDC 09042011.jpg

Drug Name: Regular Strength Aspirin EC
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: T
Dosage: 325 mg
Color(s): Orange
Shape: Round
Size (mm): 11
Score: 1
NDC:09042011

Drug Label Author: Major Pharmaceuticals Inc

This pill image is provided by the National Library of Medicine's PillBox.
Regular Strength Aspirin EC NDC 09042013.jpg

Drug Name: Regular Strength Aspirin EC
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: T
Dosage: 325 mg
Color(s): Orange
Shape: Round
Size (mm): 11
Score: 1
NDC:09042013

Drug Label Author: Major Pharmaceuticals Inc

This pill image is provided by the National Library of Medicine's PillBox.
Regular Strength Aspirin EC NDC 675440468.jpg

Drug Name: Regular Strength Aspirin EC
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: T
Dosage: 325 mg
Color(s): Orange
Shape: Round
Size (mm): 11
Score: 1
NDC:675440468

Drug Label Author: Aphena Pharma Solutions - Tennessee, LLC

This pill image is provided by the National Library of Medicine's PillBox.
Regular Strength Enteric coated aspirin NDC 578960921.jpg

Drug Name: Regular Strength Enteric coated aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: 44;227
Dosage: 325 mg
Color(s): Orange
Shape: Round
Size (mm): 9
Score: 1
NDC:578960921

Drug Label Author: Geri-Care Pharmaceutical Corp

This pill image is provided by the National Library of Medicine's PillBox.
Tri-Buffered Aspirin NDC 09042015.jpg

Drug Name: Aspirin
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: 44;183
Dosage: 325 mg
Color(s): White
Shape: Round
Size (mm): 11
Score: 1
NDC:09042015

Drug Label Author: Major Pharmaceuticals

This pill image is provided by the National Library of Medicine's PillBox.
Aspirin regular strength NDC 09042009.jpg

Drug Name: Aspirin regular strength
Ingredient(s): ASPIRIN[ASPIRIN]
Imprint: Aspirin;A1
Dosage: 325 mg
Color(s): White
Shape: Round
Size (mm): 11
Score: 1
NDC:09042009

Drug Label Author: Major Pharmaceuticals

This pill image is provided by the National Library of Medicine's PillBox.

Package and Label Display Panel

This image is provided by the National Library of Medicine.
This image is provided by the National Library of Medicine.

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Aspirin (delayed release tablet) in the drug label.

Precautions with Alcohol

  • Alcohol-Aspirin (delayed release tablet) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • ASPIRIN DELAYED RELEASE®[3]

Look-Alike Drug Names

There is limited information regarding Aspirin (delayed release tablet) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ 1.0 1.1 "Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 3 April 2014.
  2. ↑ 2.0 2.1 2.2 Brayfield, A, ed. (14 January 2014). "Aspirin". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 3 April 2014.
  3. ↑ "ASPIRIN DELAYED RELEASE- aspirin tablet, delayed release".

























Cardiology

Retrieved from "https://www.wikidoc.org/index.php?title=Aspirin_(delayed_release_tablet)&oldid=1225727"